Avalara Announces Second Quarter 2022 Financial Results
Company Cancels Earnings Call in Light of Transaction with Vista Equity Partners Second Quarter Total…
Company Cancels Earnings Call in Light of Transaction with Vista Equity Partners Second Quarter Total…
Featuring Entrepreneur, Investor and Best-Selling Author, David Meltzer, Veritone Voice Enables Meltzer to Provide his…
HOUSTON–(BUSINESS WIRE)–#business—NanoTech has joined Class 2 of the Rice Alliance Clean Energy Accelerator—Houston’s preeminent clean…
– Launched Exclusive In Vivo Gene Insertion Collaboration with Novartis to Develop Single ARCUS Nuclease…
TULSA, Okla.–(BUSINESS WIRE)–Williams (NYSE: WMB) and PennEnergy Resources, LLC, an EnCap Investments portfolio company in…
Net Sales Increased 22% to $113 Million; Net Income Decreased 1% to $6 Million; Adjusted…
NUBURU, Inc. (“NUBURU”) has entered into a business combination agreement with Tailwind Acquisition Corp. (“TWND”);…
Company Reported Interim Findings from RAMP 201 Trial of VS-6766 +/- Defactinib in Low-Grade Serous…
Second quarter 2022 revenue of $1.0 million, driven by construction support services for the 100…
Company Issues Shareholder Letter LONDON & NEW YORK–(BUSINESS WIRE)–$EVTL–Vertical Aerospace Ltd. (“Vertical” or the “Company”)…
Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio and pipeline to…
Second Quarter 2022 Financial Results Revenue of $1,177 million Reported Net Loss of $22 million,…
FRISCO, Texas–(BUSINESS WIRE)–Magellan Health, Inc. today announced it has appointed Tom Britt as chief information…
Reported net income attributable to HF Sinclair stockholders of $1,221.3 million, or $5.43 per diluted…
Reported net income attributable to HEP of $56.8 million or $0.45 per unit Announced quarterly…
Maintaining a website can be a daunting task. There are updates to be made, plugins…
— MET is the most common biomarker in patients with EGFR-mutated lung cancer who develop…
ADELAIDE, Australia, Aug. 08, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (ASX: BNO, NASDAQ:BNOX), a clinical…
Second quarter revenues of €3.2 billion1, net profit of €1.7 billion and fully diluted earnings per share…
SAN DIEGO and REDWOOD CITY, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc….